Wiki
Calcium
Calcium
Longitudinal Data
| Date | Value | Flag | Context/Notes | Source |
|---|---|---|---|---|
| 2026-03-02 | 9.9 | N | KIMS — Cycle 3 start. NM-BAPTA method. | Ishamma T M 4.pdf |
| 2026-01-22 | 10.1 | N | KIMS — NM-BAPTA method. Ref 8.60–10.20. | Ishamma T M 9.pdf |
| 2026-01-19 | 10.7 | H | KIMS — Cycle 2 start. Above reference range. NM-BAPTA method. | Ishamma T M 1 7.pdf |
| 2025-07-05 | 10.20 | N | Devi Scans — pre-AML baseline. At upper limit. | ISHAMMA T M 14.pdf |
Trend Analysis
Four data points available:
- 2025-07-05: 10.20 mg/dL — normal (at upper limit of KIMS range 8.60–10.20). Pre-AML baseline.
- 2026-01-19: 10.7 mg/dL — HIGH (above reference range 8.60–10.20). Drawn at Cycle 2 start. This mild hypercalcemia may be related to bone turnover from AML marrow involvement, increased bone resorption, or transient dehydration.
- 2026-01-22: 10.1 mg/dL — normal. Already trending down 3 days after the 10.7 peak, confirming rapid self-correction.
- 2026-03-02: 9.9 mg/dL — normal. Fully normalized by Cycle 3 start.
Transient Hypercalcemia (2026-01-19)
Calcium 10.7 mg/dL exceeded the reference range (8.60–10.20). While mild and self-resolved by Mar 2, this should be monitored — persistent or worsening hypercalcemia in AML could indicate bone involvement or other complications.
Related Pages
- Lipid Panel — Lipid panel from same dates
- Hba1C — HbA1c from same dates
- Lft — LFT from same dates
- Magnesium — Mg 1.4 (low) from Mar 2 — calcium-magnesium interaction
- Creatinine — Renal function from same dates
Sources: raw/labs/ISHAMMA T M 14.pdf, raw/labs/Ishamma T M 1 7.pdf, raw/labs/Ishamma T M 4.pdf